GC Therapeutics raised $65M in a Series A funding round led by Cormorant Asset Management to expand operations and develop cell therapies for various diseases.
Amount Raised
$65 Million
Round Type
Series A
CambridgeBiotechnologyHealth CareTherapeuticsInvestors
Description
GC Therapeutics, based in Cambridge, MA, has successfully raised $65M in Series A funding. The round saw participation from prominent investors including Mubadala Capital and Andreessen Horowitz, bringing total capital raised to $75M.
Quick answer
GC Therapeutics raised $65 Million in a Series A round, dated September 23, 2024. Investors: Pear VC, Cercano Management, Medical Excellence Capital, Bio + Health, Andreessen Horowitz, Mubadala Capital and Cormorant Asset Management. GC Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did GC Therapeutics raise?
- GC Therapeutics raised $65 Million in a Series A round on September 23, 2024.
- Who invested in GC Therapeutics?
- Pear VC, Cercano Management, Medical Excellence Capital, Bio + Health, Andreessen Horowitz, Mubadala Capital and Cormorant Asset Management are named as investors in this round.
- What does GC Therapeutics do?
- GC Therapeutics is a biopharmaceutical company focused on advancing cell therapy-based medicines.
- Where is GC Therapeutics based and how big is it?
- GC Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 38 employees.
- Who are the decision-makers at GC Therapeutics?
- Fundz holds 2 contacts at GC Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as GC Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- TRex Bio raised $42M on November 7, 2024.
- CrossBridge Bio raised $10M (Seed) on November 4, 2024.
- Aarvik Therapeutics raised $1.2M (Seed) on November 4, 2024.
- Blue Earth Therapeutics raised $77M (Series A) on October 31, 2024.
- Archon Biosciences raised $20M (Seed) on October 30, 2024.
- SynOx Therapeutics raised $92M (Series B) on October 30, 2024.
Who to call at GC Therapeutics, and when
A new round usually means GC Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day GC Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GC Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GC Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GC Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansGC Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.